本文發表於《臨床試驗競技場》,著重於探討澳洲與韓國如何解決放射性藥物臨床試驗中的主要瓶頸問題。來自Novotech的Stacy Lee闡述了如何透過高效的監管路徑、多元化的供應網絡以及多區域試驗策略,減少試驗啟動延誤情形,並為時間緊迫的放射性藥物研究提供有力支援。
Featured media on Novotech’s leadership and impact.
Expert insights and real-world perspectives.
In-depth perspectives on forces shaping clinical research.
Tracking science and trends across therapeutic areas.
Hear from experts shaping clinical development.
Conversations with leaders shaping drug development.
A global CRO and scientific partner advancing drug development.
Our impact extends beyond trials, shaping healthier futures worldwide.
A collaborative, science-driven approach.
Recognized for excellence across the industry.
Decades of clinical and scientific leadership.
A global clinical research leader with an award-winning culture.
A culture that empowers growth, innovation, and impact.
Explore career opportunities at Novotech.
Benefits and recognition that support your success.
Experts collaborating to advance clinical research.
A commitment to your growth and development.
Start your career in clinical research with Novotech.
本文發表於《臨床試驗競技場》,著重於探討澳洲與韓國如何解決放射性藥物臨床試驗中的主要瓶頸問題。來自Novotech的Stacy Lee闡述了如何透過高效的監管路徑、多元化的供應網絡以及多區域試驗策略,減少試驗啟動延誤情形,並為時間緊迫的放射性藥物研究提供有力支援。